Podiatrists in Longview, WA Accepting Medicare

7 Podiatrists found. Showing 1 - 7

Jacob Myles Mcleod, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 625 9th Ave Ste 210, Longview, WA 98632 Phone: 360-501-3400    Fax: 360-423-5682

Longview Foot & Ankle Clinic Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 783 Commerce Ave, Suite 120, Longview, WA 98632 Phone: 360-575-9161    Fax: 360-575-9306

Mr. Steven Gregory Schatz, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1114 Broadway, Longview, WA 98632 Phone: 360-577-3682    Fax: 360-577-1871

Mrs. Karla Ann Trombello, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1114 Broadway, Longview, WA 98632 Phone: 360-577-3682    Fax: 360-577-1871

Toddrick Lamont Tookes, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 783 Commerce Avenue, Ste 120, Longview, WA 98632 Phone: 360-575-9161    Fax: 360-575-9306

Ankle & Foot Clinic Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 1114 Broadway St, Longview, WA 98632 Phone: 360-577-3682    Fax: 360-577-1871

Kirkpatrick Family Care Foot & Ankle Podiatrist Medicare: Medicare Enrolled Practice Location: 783 Commerce Ave, Suite 120, Longview, WA 98632 Phone: 360-575-9161    Fax: 360-575-9161

News Archive

Vortex flow closely linked to pressure differences in ventricles of the heart

Japanese scientists at Tokyo University of Agriculture and Technology, Teikyo University of Science, and Juntendo University have found - in animal studies - a close relationship between vortex flow and pressure differences in the ventricles, or lower chambers, of the heart.

FDA approves Cyberonics re-designed AspireHC generator

Cyberonics, Inc. today announced that the United States Food and Drug Administration (FDA) has approved its re-designed AspireHC (High Capacity) generator, which was the subject of a voluntary product withdrawal in August 2011.

EpiCept receives Israeli Ministry of Health approval for Ceplene

EpiCept Corporation today announced that the Israeli Ministry of Health has approved the marketing application for Ceplene®, indicated for remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia (AML) in first remission. Megapharm Ltd. is EpiCept's partner in Israel and upon Ministry of Health approval of labeling and other technical matters the company is expected to launch Ceplene® in the first quarter of 2011.

Baroreflex activation therapy safe, effective for symptomatic advanced heart failure patients

Results of a clinical trial announced today at the American College of Cardiology Annual Scientific Session show a new type of therapy is safe and effective for symptomatic advanced heart failure patients who are already receiving optimum drug and device therapy.

Read more Medical News

› Verified 2 days ago